Matsuda Naoto

マツダナオト | Matsuda Naoto

Affiliation and department：

Research field (6)： Hygiene and public health (non-laboratory) , Hygiene and public health (laboratory) , Business administration , Clinical pharmacy , Neuroscience - general , Social psychology

Research theme for competitive and other funds (3)：

2010 - 2012 Regulation of neurotrophin secretion by exocytosis
2000 - 2004 MOLECULAR BASIS OF LEARNING AND MEMORY
2002 - 2003 ゼブラフィッシュ胚発現系を用いた軸索誘導制御機構の解析

Papers (11)：

Takafumi Wataya, Sakura Takasaki, Misuzu Hoshino, Haruki Makioka, Genshu Nakamura, Naoto Matsuda. Real-world safety of nusinersen in Japan: results from an interim analysis of a post-marketing surveillance and safety database. The International journal of neuroscience. 2023. 133. 8. 851-863
Akimichi Morita, Hidetoshi Takahashi, Kentaro Ozawa, Shinichi Imafuku, Takekuni Nakama, Kenzo Takahashi, Takashi Matsuyama, Yukari Okubo, Susumu Kitamura, Naoto Matsuda, et al. Twenty-four-week interim analysis from a phase 3 open-label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa. The Journal of dermatology. 2019. 46. 9. 745-751
Akimichi Morita, Fumikazu Yamazaki, Takashi Matsuyama, Kenzo Takahashi, Satoru Arai, Akihiko Asahina, Shinichi Imafuku, Hidemi Nakagawa, Yuichi Hasegawa, David Williams, et al. Adalimumab treatment in Japanese patients with generalized pustular psoriasis: Results of an open-label phase 3 study. The Journal of dermatology. 2018. 45. 12. 1371-1380
Naoto Matsuda, Hui Lu, Yuko Fukata, Jun Noritake, Hongfeng Gao, Sujay Mukherjee, Tomomi Nemoto, Masaki Fukata, Mu-Ming Poo. Differential activity-dependent secretion of brain-derived neurotrophic factor from axon and dendrite. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2009. 29. 45. 14185-98
Jun Noritake, Yuko Fukata, Tsuyoshi Iwanaga, Naoki Hosomi, Ryouhei Tsutsumi, Naoto Matsuda, Hideki Tani, Hiroko Iwanari, Yasuhiro Mochizuki, Tatsuhiko Kodama, et al. Mobile DHHC palmitoylating enzyme mediates activity-sensitive synaptic targeting of PSD-95. The Journal of cell biology. 2009. 186. 1. 147-60

ｍore...

MISC (5)：

Matsuda Naoto. How is the innovation of pharmaceuticals reflected in drug prices in the neurological field? - A perspective from pharmaceutical companies -. Neurological Therapeutics. 2024. 41. 3. 302-307
松田尚人. 日本の薬価制度~グローバル製薬企業から見える課題. 神経治療学. 2024. 41. 6. S162-S162
Matsuda Naoto. Challenges in drug development and expectations to the Japanese Society of Neurological Therapeutics from a pharmaceutical company's perspective. Neurological Therapeutics. 2023. 40. 3. 179-183
松田尚人. 医薬品の画期性はどう薬価に反映されるのか:製薬企業の立場から. 神経治療学. 2023. 40. 6. S122-S122
松田尚人. 製薬会社からみた医薬品開発の課題と神経治療学会への期待. 神経治療学. 2022. 39. 6. S97-S97

Patents (1)：

飼育用水槽およびこの水槽を使用した魚類等飼育装置

Education (3)：

2017 - 2019 グロービス大学院経営管理科
1996 - 1999 The University of Tokyo Graduate School of Medicine
1987 - 1993 Osaka University Faculty of Medicine Medical School

Work history (10)：

2024/07 - 現在バイオジェン・ジャパン株式会社研究開発本部
2023/08 - 現在 Juntendo University Faculty of Medicine Department of Public Health
2021/06 - 2024/06 ユーシービージャパン株式会社メディカルアフェアーズ本部
2018/09 - 2021/05 バイオジェン・ジャパン株式会社研究開発本部
2015/04 - 2018/08 アッヴィ合同会社開発本部

Show all

Association Membership(s) (13)：

Movement Disorder Society of Japan , 日本産業衛生学会 , Japanese Society of Neurology , Japan Society of Gene and Cell Therapy , Japan Epilepsy Society , Japanese Dermatological Association , Japan College of Rheumatology , Japan Society of Human Genetics , Japanese Society of Child Neurology , Japanese Society of Internal Medicine , Japanese Society of Clinical Immunology , Japanese Society for Neuroimmunology , Japanese Society of Neurological Therapeutics

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page